placeholder newsslider

News

New Technologies for Outcome Measures in Uveal Melanoma

Basel Series of Special Interest Focus Groups (SIFG) - „New Technologies for Outcome Measures in Uveal Melanoma” In Collaboration with the European Ocular Oncology Group and the International Society of Ocular Oncology

Genome editing: Commission’s Ethics Group calls for wide-ranging societal debate and global governance

The European Group on Ethics in Science and New Technologies (EGE), an independent advisory body to the Commission, has today published its Opinion on the ethics of genome editing. The Opinion analyses ethical questions raised by the application of genome editing in humans, animals and plants, and hence spans health, research, agriculture and environmental aspects.

To remedy health disparities, more scientists must ‘get political’

The pandemic has given scientists a more prominent voice in society. They need to use it to push for better health through equality.

MedOne Surgical Receives FDA Clearance for its MicroDose Injector

MedOne Surgical announced the FDA 510(k) clearance of its MicroDose Injector device for low volume ophthalmic injections into the subretinal space. The pneumatically driven syringe system allows the surgeon to utilize a pneumatic air source, such as a vitrectomy system, to deliver a low volume injection into the subretinal space.

How to navigate authorship of scientific manuscripts

The importance of publications won’t come as news to anyone who has been in academia for a while. Still, Rolfs’s comments underscore the importance of not just doing good science, but also ensuring you receive appropriate recognition for it—particularly when it comes to authorship.

High-tech contact lenses are straight out of science fiction—and may replace smart phones

Over the years, new scientific discoveries have led to softer and more comfortable contact lenses. And now, research bringing together chemistry, biology and microelectronics is resulting in contact lenses that are straight out of science fiction.

The Children’s Eye Foundation of AAPOS Debuts “THE CURIOUS EYE” Interactive Storybook

The Children’s Eye Foundation of AAPOS unveiled the world’s first interactive children’s book to help screen for color vision deficiency (CVD), commonly known as color blindness. The foundation has posted a free digital version of THE CURIOUS EYE at thecuriouseye.org and published a first-run, hardcover book for its member pediatric ophthalmologists.

Commission appoints two new members to the Group of Chief Scientific Advisors to the European Commission

Commissioner Gabriel appointed two new members to the European Commission’s Group of Chief Scientific Advisors (GCSA) for the next three years.

Oxford Finance Provides $125 Million Credit Facility to Kala Pharmaceuticals

Oxford Finance has announced the closing of a $125 million senior secured term loan with Kala Pharmaceuticals. Proceeds from the transaction will be used to refinance existing indebtedness and provide additional growth capital for the company’s marketing of its two approved ophthalmic products.

Statement by the EIC Advisory Board and the ERC Scientific Council

The importance of knowledge creation and research for our well-being and the prosperity of our society and economies cannot be overstated. The ability to formulate questions and to seek answers to understand the world around us is a distinguishing feature of being human.

Nanoscope presents optical gene delivery

Nanoscope Technologies LLC, a biotechnology company developing gene therapies for treatment of retinal diseases, is featuring multiple scientific presentations highlighting its groundbreaking research on optical gene delivery for vision restoration and OCT-guided electrophysiology platforms for characterization of retinal degeneration and assessment of efficacy of cell-gene therapy at the 2021 ARVO annual meeting

Glaukos Expands its Preserflo MicroShunt Relationship With Santen via New License Agreement

Glaukos announced that it has entered into a new development and commercialization license agreement with Santen Pharmaceutical for the Preserflo MicroShunt (development code: DE-128), superseding the previous collaboration and distribution agreements between the two parties.

‘Hybrid’ scientific conferences aim to offer the best of in-person and virtual meetings

Last year, the COVID-19 pandemic upended the conference experience for researchers around the globe as scientific societies canceled in-person meetings and scrambled to hold virtual events in their place—with varying success.

Even in a pandemic, child vision tests are crucial

It's critical for parents to maintain their children's vision checkups during the COVID-19 pandemic, an expert says.

FDA Approves Bausch + Lomb ClearVisc Dispersive Ophthalmic Viscosurgical Device (OVD)

Bausch + Lomb, announced that the FDA has approved ClearVisc dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery.